Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News GSK American Depositary Shares Representing 2 Ordinary Shares GSK

Consumer Cyclical

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with... see more

Add To Watchlist

Recent & Breaking News (NYSE:GSK)

North American Pharma-Biotech Sector to Wrap Up Construction on 157 Projects Worth $1.3 Billion in Third-Quarter 2014, an Industrial Info News Alert

Marketwired August 20, 2014

Potential Payoffs Spur Big Board Biotech Action

Accesswire August 12, 2014

GSK's COPD.com Relaunch Promotes Understanding and Dialogue about COPD

PR Newswire August 5, 2014

GSK's Tanzeum(TM) is now available in pharmacies in the U.S.

PR Newswire July 29, 2014

FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States

PR Newswire July 24, 2014

GSK CEO and CFO Interviewed on Q2 2014 Results and Strategy Update

PR Newswire July 23, 2014

GSK and Theravance Announce Initiation of Phase III Programme With Fixed Dose Triple Combination Treatment FF/UMEC/VI in Patients With COPD

Marketwired July 16, 2014

Anoro(R) Ellipta(R) (Umeclidinium/Vilanterol) Gains Approval in Japan for the Treatment of COPD

Marketwired July 7, 2014

GSK and Theravance Announce Submission to US Regulatory Authorities for Fluticasone Furoate/Vilanterol in Asthma

Marketwired June 30, 2014

Triumeq® (dolutegravir/abacavir/lamivudine) single-tablet regimen receives positive CHMP opinion in Europe for the treatment of HIV

PR Newswire June 27, 2014

IPO Report: KineMed (KNMD)

Equities.com June 24, 2014

ViiV Healthcare announces new collaboration with Janssen to investigate single-tablet regimen for maintenance treatment of HIV-1

PR Newswire June 12, 2014

GSK and Theravance Announce Positive Data From Two Studies Evaluating the Efficacy and Safety of Incruse(TM) Ellipta(R) When Added to Relvar(R)/Breo(R) Ellipta(R) in Patients With COPD

Marketwired June 11, 2014

National Survey Identifies Potential Barriers to HIV Treatment Use in U.S.

PR Newswire June 10, 2014

GSK presents positive data at ATS 2014 from study evaluating efficacy and safety of Incruse(TM) Ellipta® added to Advair® Diskus® in patients with COPD

PR Newswire May 19, 2014

GSK and Genmab Announce Topline Results from a Pivotal Head to Head Study of Ofatumumab in Combination With Chemotherapy vs Rituximab in Combination with Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma

GlobeNewswire May 19, 2014

Chinese drugmaker CEO jumps to his death amidst bribery probe

Canadian Press May 19, 2014

GlaxoSmithKline (GSK) accused by Chinese police of bribing doctors

Canadian Press May 14, 2014

Anoro(R) (Umeclidinium/Vilanterol) Gains Marketing Authorisation in Europe for the Treatment of COPD

Marketwired May 8, 2014

GSK, Triangle Community Foundation Issue Call for Applications Totaling $400,000 in GSK IMPACT Awards

PR Newswire May 6, 2014